{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-26-000021","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.609182+00:00","generated_at":"2026-05-14T23:55:18.476386+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"confidence":"high","headline":"Indivior launches $175M accelerated share repurchase with Barclays","bullets":["Initial prepayment of $175M; received 3,717,473 shares from Barclays.","Final share count based on VWAP during term; settlement by June 22, 2026.","Part of existing $400M buyback program; $100M remains for future repurchases.","Company reaffirms prior financial guidance; ASR reflects confidence in strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-26-000021","json":"https://secwatch.observer/filing/0001625297-26-000021.json","markdown":"https://secwatch.observer/filing/0001625297-26-000021.md","text":"https://secwatch.observer/filing/0001625297-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/0001625297-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529726000021/indv-20260504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:55:18.476386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}